It looks like I will be enjoying a snow storm this week as I take another road trip for the North Carolina Integrative Medicine Society Conference on Friday and Saturday in High Point, NC. The looming storms I am sure will bring me back to my mid-western weather roots. Except with a few more Southern drivers.
I am truly looking forward to connecting with and many friends this weekend at the event, and I was wondering about what COOL things we will bring to each other to share about what we have learned over the past year.
There will be a few of us biological- and metabolic-medicine nerds sprinkled in among many functional- and integrated-medicine practitioners and vendors.
After 26 years of study into the cause of accelerated aging and degenerative disease, I have become a bit of a minimalist and really enjoy finding the core issues that patients and physicians should really focus on.
Understanding metabolic medicine should really be at the forefront of what we discuss with patients, and why we select certain products and therapies.
Want to look at a viewpoint that minimizes the confusing world of genetics and proteomics as perhaps job creators—but probably not core solutions—to cancer or other metabolic disease?
For the past 2 years, I have been studying from an amazingly well-written and important textbook that I feel should be required reading for all serious students of metabolic medicine.
Released in 2012, Dr. Thomas Seyfried’s landmark text, Cancer as a Metabolic Disease: On the Origin, Management and Prevention of Cancer, is a wonderful, scientifically based expert’s textbook in metabolic disease and its medicine.
The book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg’s well-known theory that all cancer is a disease of energy metabolism. However, Warburg did not link his theory to the “hallmarks of cancer,” and thus his theory was discredited.
This book aims to provide evidence through case studies that cancer is primarily a metabolic disease, requiring metabolic solutions, for its management and prevention. Support for this position is derived from critical assessment of current cancer theories and its genetic leanings to the detriment of many.
Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate.
Anova Health is proud of its commitment to representing and stocking products that deliver quality and effectiveness where it counts. We do not have the desire to be all things to all people, or stock products that people might buy, but are mere window dressing to the important core issues at hand.
Whether it is cancer or the modern-day plagues of diabetes, obesity and cardiovascular disease, Anova Health will continue to research, teach and bring cutting-edge tools to the practitioner market. Effectiveness and simplicity of protocol is our goal.
From the cutting edge in molecular-hydrogen technology to our new medical foods and affordable, fat-releasing LLLT technologies, you can count on us digging and researching to find you the very best in nutritional and metabolic medicine therapies.
Speak Your Mind